SEC Filing Summary: Colfax Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Colfax Corporation on October 31, 2019. The filing serves to report the company's financial results for the third quarter ended September 27, 2019. The registrant is incorporated in Delaware and trades on the New York Stock Exchange under the symbol CFX.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the text of this 8-K.
Material Changes
No material changes or comparative financial data are detailed in the body of this filing. The document solely announces the release of third-quarter results.
Guidance, Outlook, and Management Commentary
Management scheduled a conference call for 8:00 a.m. Eastern on October 31, 2019, to discuss the financial results. The filing does not contain specific guidance, risk factors, or unusual items within its text; such details are expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for actual Q3 2019 revenue, earnings, and cash flow figures.
- Verify the company's forward-looking guidance and outlook statements provided during the October 31 conference call.
- Confirm the impact of the third-quarter results on the company's full-year 2019 performance targets.
- Note that the filing metadata lists "Enovis CORP" as the company name, but the filing text explicitly identifies the registrant as Colfax Corporation (Enovis was formed later via a spin-off).